# EDGAR Filing Document

**Accession Number:** 0000925741
**File Stem:** 0001437749-25-022729
**Filing Date:** 2025-7
**Character Count:** 2717
**Document Hash:** 026f885201b11d4460b7348801a5d2a1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-25-022729.hdr.sgml**: 20250814

**ACCESSION NUMBER**: 0001437749-25-022729

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250715

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BioCardia, Inc.
- **CENTRAL INDEX KEY:** 0000925741
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 232753988
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 320 SOQUEL WAY
- **CITY:** SUNNYVALE
- **STATE:** CA
- **ZIP:** 94085
- **BUSINESS PHONE:** 650-226-0123

**MAIL ADDRESS:**
- **STREET 1:** 320 SOQUEL WAY
- **CITY:** SUNNYVALE
- **STATE:** CA
- **ZIP:** 94085

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Tiger X Medical, Inc.
- **DATE OF NAME CHANGE:** 20110616

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Cardo Medical, Inc.
- **DATE OF NAME CHANGE:** 20081027

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CLICKNSETTLE COM INC
- **DATE OF NAME CHANGE:** 20000823

**BioCardia, Inc.**

320 Soquel Way

Sunnyvale, California 94085

July 15, 2025

***<u>Via EDGAR</u>***

U.S. Securities and Exchange Commission<br> Division of Corporation Finance<br> Office of Life Sciences<br> 100 F Street, NE

Washington, D.C. 20549-3561

Attn: Joshua Gorsky

Re: BioCardia, Inc. Registration Statement on Form S-3 Filed July 9, 2025 File No. 333-288592

**<u>Acceleration Request</u>**

Requested Date: July 17, 2025

Requested Time: 4:30 p.m. Eastern Time

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioCardia, Inc. (the "Company") hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-288592) (the "Registration Statement"), be declared effective at the "Requested Date" and "Requested Time" set forth above or as soon thereafter as practicable, or at such later time as the Company may request by telephone to the staff of the Securities and Exchange Commission.

The Company hereby authorizes Austin March of Wilson Sonsini Goodrich & Rosati, P.C., counsel for the Company, to make such request on the Company's behalf.

The Company requests that it be notified of the effectiveness of the Registration Statement by contacting Austin March at (512) 338-5410 or amarch@wsgr.com.

---

| | |
|:---|:---|
| Sincerely, | Sincerely, |
| BIOCARDIA, INC. | BIOCARDIA, INC. |
| By: | /s/ David McClung |
|  | David McClung<br> Chief Financial Officer |

---

cc: Peter Altman, BioCardia, Inc.

Austin March, Esq., Wilson Sonsini Goodrich & Rosati, P.C.